A systematic review of the effectiveness of adalimumab

242
Health Technology Assessment reports published to date
No. 4
A systematic review of the effectiveness
and cost-effectiveness of neuroimaging
assessments used to visualise the
seizure focus in people with refractory
epilepsy being considered for
surgery.
By Whiting P, Gupta R, Burch J,
Mujica Mota RE, Wright K, Marson A,
et al.
No. 5
Comparison of conference abstracts
and presentations with full-text
articles in the health technology
assessments of rapidly evolving
technologies.
By Dundar Y, Dodd S, Dickson R,
Walley T, Haycox A, Williamson PR.
No. 6
Systematic review and evaluation of
methods of assessing urinary
incontinence.
By Martin JL, Williams KS, Abrams
KR, Turner DA, Sutton AJ, Chapple C,
et al.
No. 7
The clinical effectiveness and costeffectiveness
of newer drugs for children
with epilepsy. A systematic review.
By Connock M, Frew E, Evans B-W,
Bryan S, Cummins C, Fry-Smith A,
et al.
No. 8
Surveillance of Barrett’s oesophagus:
exploring the uncertainty through
systematic review, expert workshop and
economic modelling.
By Garside R, Pitt M, Somerville M,
Stein K, Price A, Gilbert N.
No. 9
Topotecan, pegylated liposomal
doxorubicin hydrochloride and
paclitaxel for second-line or subsequent
treatment of advanced ovarian cancer: a
systematic review and economic
evaluation.
By Main C, Bojke L, Griffin S,
Norman G, Barbieri M, Mather L,
et al.
No. 10
Evaluation of molecular techniques
in prediction and diagnosis of
cytomegalovirus disease in
immunocompromised patients.
By Szczepura A, Westmoreland D,
Vinogradova Y, Fox J, Clark M.
No. 11
Screening for thrombophilia in high-risk
situations: systematic review and costeffectiveness
analysis. The Thrombosis:
Risk and Economic Assessment of
Thrombophilia Screening (TREATS)
study.
By Wu O, Robertson L, Twaddle S,
Lowe GDO, Clark P, Greaves M,
et al.
No. 12
A series of systematic reviews to inform
a decision analysis for sampling and
treating infected diabetic foot
ulcers.
By Nelson EA, O’Meara S, Craig D,
Iglesias C, Golder S, Dalton J,
et al.
No. 13
Randomised clinical trial, observational
study and assessment of costeffectiveness
of the treatment of varicose
veins (REACTIV trial).
By Michaels JA, Campbell WB,
Brazier JE, MacIntyre JB, Palfreyman
SJ, Ratcliffe J, et al.
No. 14
The cost-effectiveness of screening for
oral cancer in primary care.
By Speight PM, Palmer S, Moles DR,
Downer MC, Smith DH, Henriksson M
et al.
No. 15
Measurement of the clinical and costeffectiveness
of non-invasive diagnostic
testing strategies for deep vein
thrombosis.
By Goodacre S, Sampson F, Stevenson
M, Wailoo A, Sutton A, Thomas S, et al.
No. 16
Systematic review of the effectiveness
and cost-effectiveness of HealOzone ®
for the treatment of occlusal pit/fissure
caries and root caries.
By Brazzelli M, McKenzie L, Fielding
S, Fraser C, Clarkson J, Kilonzo M,
et al.
No. 17
Randomised controlled trials of
conventional antipsychotic versus new
atypical drugs, and new atypical drugs
versus clozapine, in people with
schizophrenia responding poorly
to, or intolerant of, current drug
treatment.
By Lewis SW, Davies L, Jones PB,
Barnes TRE, Murray RM, Kerwin R,
et al.
No. 18
Diagnostic tests and algorithms used in
the investigation of haematuria:
systematic reviews and economic
evaluation.
By Rodgers M, Nixon J, Hempel S,
Aho T, Kelly J, Neal D, et al.
No. 19
Cognitive behavioural therapy in
addition to antispasmodic therapy for
irritable bowel syndrome in primary
care: randomised controlled
trial.
By Kennedy TM, Chalder T,
McCrone P, Darnley S, Knapp M,
Jones RH, et al.
No. 20
A systematic review of the clinical
effectiveness and cost-effectiveness of
enzyme replacement therapies for
Fabry’s disease and
mucopolysaccharidosis type 1.
By Connock M, Juarez-Garcia A, Frew
E, Mans A, Dretzke J, Fry-Smith A, et al.
No. 21
Health benefits of antiviral therapy for
mild chronic hepatitis C: randomised
controlled trial and economic
evaluation.
By Wright M, Grieve R, Roberts J,
Main J, Thomas HC on behalf of the
UK Mild Hepatitis C Trial Investigators.
No. 22
Pressure relieving support surfaces: a
randomised evaluation.
By Nixon J, Nelson EA, Cranny G,
Iglesias CP, Hawkins K, Cullum NA, et al.
No. 23
A systematic review and economic
model of the effectiveness and costeffectiveness
of methylphenidate,
dexamfetamine and atomoxetine for the
treatment of attention deficit
hyperactivity disorder in children and
adolescents.
By King S, Griffin S, Hodges Z,
Weatherly H, Asseburg C, Richardson G,
et al.
No. 24
The clinical effectiveness and costeffectiveness
of enzyme replacement
therapy for Gaucher’s disease:
a systematic review.
By Connock M, Burls A, Frew E,
Fry-Smith A, Juarez-Garcia A,
McCabe C, et al.
No. 25
Effectiveness and cost-effectiveness of
salicylic acid and cryotherapy for
cutaneous warts. An economic decision
model.
By Thomas KS, Keogh-Brown MR,
Chalmers JR, Fordham RJ, Holland RC,
Armstrong SJ, et al.
No. 26
A systematic literature review of the
effectiveness of non-pharmacological
interventions to prevent wandering in
dementia and evaluation of the ethical
implications and acceptability of their
use.
By Robinson L, Hutchings D, Corner
L, Beyer F, Dickinson H, Vanoli A, et al.
No. 27
A review of the evidence on the effects
and costs of implantable cardioverter
defibrillator therapy in different patient
groups, and modelling of costeffectiveness
and cost–utility for these
groups in a UK context.
By Buxton M, Caine N, Chase D,
Connelly D, Grace A, Jackson C, et al.